The global role of biotechnology for non communicable disorders

Publication date: Available online 2 August 2018Source: Journal of BiotechnologyAuthor(s): Serena Zacchigna, Mauro GiaccaAbstractThe World Health Organization (WHO) has tagged non-communicable diseases (NCDs) as one of the twenty-first century’s major development challenges. NCDs account for over 15 million deaths annually and over 80 per cent of those deaths occur in developing countries and among the poorest populations. Biotechnology presents unique opportunities to improve the early diagnosis and the treatment of NCDs. This review describes the major applications of biotechnology for a better clinical management of NCDs, i.e. the implementation of innovative diagnostic approaches and the production of innovative treatments, including those based on monoclonal antibodies, recombinant proteins, regulatory nucleic acids and cell-based therapies for regenerative medicine. In this context, it also examines the major challenges faced by biotechnology in developing countries.
Source: Journal of Biotechnology - Category: Biotechnology Source Type: research